Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination

Current vaccines, which induce a B-cell-mediated antibody response against the spike protein of SARS-CoV-2, have markedly reduced infection rates. However, the emergence of new variants as a result of SARS-CoV-2 evolution requires the development of novel vaccines that are T-cell-based and that targ...

Full description

Bibliographic Details
Main Authors: Amal Hasan, Mohammad R. Al-Mulla, Jehad Abubaker, Fahd Al-Mulla
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1969855